![]() |
市场调查报告书
商品编码
1403473
到 2030 年药品胶囊检查赌注市场预测:按自动化程度、产能、整合程度、技术、应用、最终用户和地区进行的全球分析Pharmaceutical Capsule Checkweigher Market Forecasts to 2030 - Global Analysis By Automation Level, Capacity, Integration Level, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球药品胶囊支票投注市场在预测期内将以 6.7% 的复合年增长率成长。
专为药用胶囊製造的检重秤细分市场称为药用胶囊检重秤市场。它专注于此类设备的生产、分销和使用。这种精密设备对于药品製造至关重要,可以确保每个胶囊具有相同的重量,遵守严格的法规并维持产品品质。校准机是药品製造流程的关键要素,有助于消除给药差异并提高患者的安全性和疗效。
药品製造商努力维持严格的品管要求,降低製造成本并提高效率。为了确保药物胶囊符合规定的重量参数,Checkwager 在称重过程中提供即时监控和准确性。此外,透过能够有效率、准确地测量物体,自动检查器可以帮助简化生产过程、降低错误率并提高整体业务效率。
对于製药公司,尤其是资金有限的小型和成长型公司来说,与检重设备的先进技术和精度相关的高昂初期成本构成了障碍。对于希望改进品管程序的公司来说,购买、部署和整合到当前生产线的成本可能是一个障碍。为了进一步增加整体财务负担,投资不仅限于采购,还包括验证、维护和培训成本。
需要提高生产能力来满足世界对药品日益增长的需求,而有效且可靠的品管程序对此至关重要。在这种情况下,测试砝码至关重要,因为它们可以确保药物胶囊的准确重量并有助于确保药品的整体品质。此外,随着製药公司提高产量以满足医疗保健系统不断增长的需求,CheckWager 有助于维持给药准确性并避免给药和给药问题,使用极为重要。
诈欺的存取和有害活动可能会针对零售称重设备产生的资料。资料可以包括有关药物配方和製造程序的重要资讯。确保这些资讯的隐私性、准确性和可近性对于防止智慧财产权盗窃、伪造和药品生产中断至关重要。为了保护敏感资料,秤製造商和使用者必须实施强有力的网路安全措施,包括加密、存取限制和频繁的安全审核。
製药业务受到生产放缓、全球供应链中断以及必需品优先排序的影响,所有这些都影响了零售称重设备的需求。儘管为应对这场流行病,药品生产急剧增加,但对基本治疗的关注已经改变了生产重点。为了应对不确定性,一些製造商已推迟或重新考虑购买新机械,例如称重机。封锁和旅行限制也使得安装和维护检重设备变得困难。
预计自动检查器市场将在整个预测期内快速成长。这是因为它能够在药物胶囊製造过程中提高营运效率,降低人事费用,并提供准确、快速、即时的重量测量。此外,自动秤提供了一种优雅的方式,可以将品管顺利地整合到对准确性和精密度至关重要的製药操作中的大批量生产中。
独立检查器预计将在预测期内快速成长,因为它们提供不需要重大修改并且可以轻鬆整合到当前製药生产线的独立解决方案。此外,寻求有效的品管解决方案而无需重组整个供应链的製药公司可能会发现这种弹性很有吸引力。由独立称重机提供药物胶囊的精确重量测量,确保符合法律要求并维持产品品质。
在亚太地区,称重机的使用显着增加,该地区的製药商优先考虑提高生产效率、确保法律规章规性并维持最高的产品品质标准。该地区占据了最大的市场份额。此外,自动检重技术提供的功能符合人们对药物配方精确度和精确度的日益重视。由于监管机构强调准确的给药测量和遵守国际品质标准,检重秤已成为药品生产业务的重要组成部分。
北美地区正在经历良好的成长。严格的法规环境,例如美国食品药物食品药物管理局(FDA) 实施的监管环境,需要严格的品管程序,使得支票在药品製造业务中变得越来越重要。此外,由于关注患者安全和准确估计给药的需要,北美製药公司越来越多地使用秤来维持监管合规性。
2023 年 7 月 Thermo Fisher Scientific, Inc.(以下简称「Thermo Fisher」)是科学服务领域的全球领导者,今天宣布,该公司是核准治疗方法和治疗方法。签署最终协议收购供应商CorEvitas, LLC。
13.1 OCS检重秤有限公司
13.2 赛默飞世尔科技公司
13.3 安立公司
13.4 多佛公司
13.5上海比隆仪器有限公司
13.6 梅特勒-托利多国际公司
13.7 Wipotec-OCS 有限公司
13.8 碧彩有限公司
13.9 世宗製药科技
According to Stratistics MRC, the Global Pharmaceutical Capsule Checkweigher Market is growing at a CAGR of 6.7% during the forecast period. The market segment for check-weighing equipment made especially for pharmaceutical capsules is known as the Pharmaceutical Capsule Checkweigher Market. It is concentrated on the production, distribution, and use of this type of equipment. By ensuring that each capsule weighs identically, ensuring that strict regulations are adhered to, and preserving product quality, this precision equipment is essential to the manufacturing of pharmaceuticals. Checkweighers, a crucial component of the pharmaceutical production process, help to eliminate dosage discrepancies, improving patient safety and efficacy.
Manufacturers of pharmaceuticals strive intensively to maintain strict quality control requirements, lower production costs, and increase efficiency. To ensure that pharmaceutical capsules satisfy specified weight parameters, checkweighers provide real-time monitoring and precision in the weighing process, which is crucial to attaining these objectives. Additionally, because they can measure objects efficiently and accurately, automated check weighers help to streamline production processes, reduce mistake rates, and improve overall operational efficiency.
Pharmaceutical producers have a hurdle because of the high upfront expenses associated with check weighing equipment's sophisticated technology and precision, particularly for smaller or growing businesses with limited funding. The cost of purchasing, placing in position, and integrating checkweighers into current production lines can be a barrier for businesses seeking to improve their quality control procedures. To further increase the entire financial commitment, the investment expands beyond acquisition to cover costs for validation, maintenance, and training.
Increased manufacturing capacity is required to meet the growing global demand for medicines, which emphasizes the importance of effective and dependable quality control procedures. In this context, check weighers are essential as they ensure the exact weight of pharmaceutical capsules, which helps to ensure the total quality assurance of drugs. Additionally, the use of check weighers is crucial to preserving dosage accuracy and avoiding problems with under or overdosing as pharmaceutical businesses increase their production volumes to meet the growing demands of the healthcare system.
Unauthorized access or harmful activity may target the data produced by checkweighing equipment, which may contain critical information regarding pharmaceutical formulations and production procedures. It is crucial to ensure the privacy, accuracy, and accessibility of this information in order to prevent intellectual property theft, counterfeiting, and interruptions in the production of pharmaceuticals. To protect sensitive data, checkweigher manufacturers and users must set strong cybersecurity measures in place, such as encryption, access limits, and frequent security audits.
The pharmaceutical business was impacted by production slowdowns, global supply chain disruptions, and the prioritization of necessities, which all had an impact on the demand for checkweighing equipment. Despite the fact that pharmaceutical manufacturing increased dramatically in response to the epidemic, priorities in production shifted as a result of the primary focus on essential treatments. To manage uncertainty, a few manufacturers experienced delays or reconsidered their purchases of new machinery, such as checkweighers. Lockdowns and travel restrictions also made it difficult to install and maintain checkweighing equipment.
The market for automatic checkweighers is anticipated to grow at a rapid pace throughout the projected period because of its capacity to improve operational effectiveness, reduce labor costs, and offer accurate, fast, and real-time weight measurements in the pharmaceutical capsule production process. Additionally, automatic checkweighers provide a sophisticated way to smoothly integrate quality control into high-volume manufacturing in the pharmaceutical business, where accuracy and precision are critical.
Because it provides a stand-alone solution that can be readily integrated into current pharmaceutical production lines without requiring significant changes, the Standalone Checkweighers segment is anticipated to grow at a rapid pace throughout the projected period. Moreover, pharmaceutical businesses looking for effective quality control solutions without having to reorganize their entire supply chain may find this flexibility appealing. Accurate weight measurements for pharmaceutical capsules are provided by standalone checkweighers, ensuring adherence to legal requirements and preserving product quality.
The usage of checkweighers is significantly increasing in the Asia-Pacific area, where pharmaceutical manufacturers prioritize improving production efficiency, guaranteeing regulatory compliance, and maintaining the highest standards of product quality. This region held the largest share of the market. Furthermore, the capabilities provided by check weighing technology are in line with the growing emphasis on accuracy and precision in dosage formulations. Checkweighers are an essential part of pharmaceutical manufacturing operations because regulatory bodies emphasize the importance of precise dosage measurements and compliance with international quality standards.
North America region is experiencing lucrative growth. Strict regulatory environments, such as those imposed by the Food and Drug Administration (FDA) in the United States, require stringent quality control procedures, which increases the significance of checkweighers in pharmaceutical production operations. Moreover, checkweighing equipment is becoming more widely used by pharmaceutical businesses in North America to maintain regulatory compliance, with a focus on patient safety and the necessity for precise dosage estimates.
Some of the key players in Pharmaceutical Capsule Checkweigher market include: OCS Checkweighers GmbH, Thermo Fisher Scientific Inc., Anritsu Corporation, Dover Corporation, Shanghai Bilon Instrument Co., Ltd, Mettler-Toledo International Inc., Wipotec-OCS GmbH, Bizerba GmbH & Co. KG and Sejong Pharmatech.
In July 2023, Thermo Fisher Scientific Inc ("Thermo Fisher"), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC, a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies.
13.1 OCS Checkweighers GmbH
13.2 Thermo Fisher Scientific Inc.
13.3 Anritsu Corporation
13.4 Dover Corporation
13.5 Shanghai Bilon Instrument Co., Ltd
13.6 Mettler-Toledo International Inc.
13.7 Wipotec-OCS GmbH
13.8 Bizerba GmbH & Co. KG
13.9 Sejong Pharmatech